Haynes wins Fleming Award from Infectious Diseases Society

posted January 16th, 2012

Barton Haynes, M.D., director of the Duke Human Vaccine Institute (DHVI), has won the 2011 Alexander Fleming Award from the Infectious Diseases Society of America (IDSA).

The award honors noteworthy contributions to acquiring and disseminating knowledge about infectious diseases.

“It is wonderful to see Bart honored with this lifetime achievement award,” said School of Medicine Dean Nancy Andrews, M.D.,Ph.D. “He has made remarkable contributions to our understanding of vaccine immunology. Through his leadership of the Duke Human Vaccine Institute, he has focused the efforts of a strong, multidisciplinary team on preventing some of the toughest, and most important, challenges to health around the world.”

Haynes, the Frederic M.Hanes Professor of Medicine and Immunology, is known for his work on the origins and development of the human immune system, for his work in HIV pathogenesis and HIV vaccine development, and for work performing the basic thymus biology studies that, with Louise Markert at Duke, made possible human thymus transplantation as a curative treatment for thymus aplasia (DiGeorge Syndrome).

In addition to directing DHVI, Haynes is director of the NIH, NIAID Center for HIV/AIDS Vaccine Immunology (CHAVI) consortium, the largest consortium of academic and research centers funded to overcome obstacles that stand in the way of HIV vaccine development.

He also is a principal investigator of a Vaccine Development Center of the Collaboration for AIDS Vaccine Discovery funded by the Bill and Melinda Gates Foundation. He has led and contributed to numerous studies into the nature of HIV and each year has made progress in unlocking the secrets of immunity to this virus.

The IDSA award comes with a $3,500 honorarium.

Commenting is not available in this weblog entry.